Chicago, Illinois (PRWEB) January 12, 2016
ktMINE, an innovation and intangible asset information services firm, announced today that they will be exhibiting at the 2016 Pharma Market Research Conference, taking place from February 3-4 2016, in Parsippany, New Jersey.
ktMINE’s David R. Jarczyk, President & CEO, and Cash McNeel, Business Development Manager, will be representing ktMINE in the exhibit hall. ktMINE’s products can enhance pharmaceutical strategic analyses through innovation and intangible asset data. ktMINE will be revealing their new product, ktMINE Search. A company’s current intangible asset portfolio, recent activity, and future investments can be accessed from the all-in-one search of innovation and intangible asset data.
The Pharma Market Research Conference is the premier gathering of senior-level pharmaceutical, biotechnology, medical device and diagnostics executives in market research. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, connections and perspectives. This year’s conference includes sessions on market research for tracking competitor launches, licensing and acquisitions, new technologies, competitive intelligence, and building customer experience. Session speakers are represented from companies including Pfizer, Bayer, Celgene, Merck, Bristol-Myers Squibb, Ipsen, Aetna, Astellas Pharma, Quest Diagnostics and Purdue Pharmaceuticals.
ktMINE, headquartered in Chicago, IL, is an innovation and intangible asset information firm founded in 2008. Focused on mining, organizing and connecting the world’s IP information, ktMINE provides businesses across the globe access to insights on industry players, technologies and developments. For more information visit http://www.ktmine.com, or contact ktMINE at firstname.lastname@example.org.